Onconova Therapeutics announces closing of public offering of common stock
Onconova Therapeutics announced the closing of its public offering of 2,476,190 shares of its common stock at a price to the public of $2.10 per share. The gross proceeds from the offering are approximately $5.20 million, before underwriting discounts and commissions and estimated offering costs. April 26, 2017